News & Press

Contract Pharmacal to buy 7th Hauppauge Building

Featured in Long Island Business News

"At this rate, they may need to rename it to the Contract Pharmacal Industrial Park. The manufacturer of the over-the-counter drugs and dietary supplements, which currently operates out of six buildings in the Hauppauge Industrial Park, is in the process of purchasing and renovating a seventh facility in the park - a 70,000 square-foot space located at 145 Oser Ave. Contract Pharmacal Corp. will spend $5.25 million on the purchase and an additional $2.5 million to renovate it for use as a packaging facility for the company’s pharmaceutical products." More >>
Contract Pharmacal to hire 40 in new expansion

Featured on Newsday.com

A fast-growing drugmaker expects to hire at least 40 workers through the expansion of one of its six buildings in Hauppauge, officials said this week.
Contract Pharmacal Corp. wants to enlarge a mezzanine area inside 135 Adams Ave. to accommodate production equipment. The $2.5-million project will start in the fall.
The company, founded in 1971, makes generic over-the-counter drugs, vitamins and dietary supplements for pharmaceutical giants and retailers. It is owned by the Wolf family. More >>
Two Suffolk pharmaceutical firms look to expand

Featured on Newsday.com

A fast-growing drugmaker expects to hire at least 40 workers through the expansion of one of its six buildings in Hauppauge, officials said this week. Contract Pharmacal Corp. wants to enlarge a mezzanine area inside 135 Adams Ave. to accommodate production equipment. The $2.5-million project will start in the fall. The company, founded in 1971, makes generic over-the-counter drugs, vitamins and dietary supplements for pharmaceutical giants and retailers. It is owned by the Wolf family. More >>
Contract Pharmacal gets $1.05M grant from ESD

Featured in Newsday

The upgrades and expansion to Contract Pharmacal's operations will help retain 457 jobs and create 168 new ones within the next few years. More >>

with Dr. Jeff Reingold, Senior Director, R&D

PL BUYER: October 2010 More >>